PAVmed
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $6,000 | $8 | $10 | $996 |
Gross Profit | -35,000 | -71 | -38 | -385 |
EBITDA | -4,715,000 | 18,670 | 1,218 | 60,961 |
EBIT | -4,715,022 | 18,627 | 1,149 | 60,723 |
Net Income | -11,921 | 18,968 | 1,431 | 64,399 |
Net Change In Cash | 6,000 | 8 | 10 | 996 |
Free Cash Flow | -1,178,000 | -1,581,000 | 90 | -8,889 |
Cash | 4,004,000 | 2,700 | 1,185 | 765 |
Basic Shares | 18,084,653 | 524 | 11,198 | 10,005 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,995 | $2,452 | $377 | $500 |
Gross Profit | -3,043 | -3,968 | -3,237 | -85 |
EBITDA | 29,670 | -75,742 | -99,412 | -55,900 |
EBIT | 28,472 | -78,674 | -101,966 | -56,126 |
Net Income | 39,791 | -64,175 | -88,983 | -50,347 |
Net Change In Cash | 2,995 | 2,452 | 377 | 500 |
Cost of Revenue | 60,002 | |||
Free Cash Flow | -33,609 | -52,278 | -72,525 | -42,060 |
Cash | 1,185 | 19,639 | 39,744 | 77,258 |
Basic Shares | 9,672 | 7,231 | 5,938 | 5,167 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.74 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.19 |
2024-09-30 | -$0.54 |
